Skip to main content

Home/ science/ Group items tagged patient

Rss Feed Group items tagged

Skeptical Debunker

Controversial Studies Trigger Dropoff in Osteoporosis Treatment - 0 views

  • The North American Spine Society and the Society of Interventional Radiology have pointed to flaws in both studies. And earlier studies, published over 15 years, found major benefits to kyphoplasty and a related procedure called vertebroplasty. "We're missing opportunities for patients to receive a safe and effective treatment that can significantly reduce their pain and disability," said Malamis, an interventional radiologist. The procedures are used to treat vertebral compression fractures in patients with osteoporosis and other conditions that result in brittle bones. In a vertebroplasty, an acrylic cement is injected into a fractured vertebra. In a kyphoplasty, a balloon-tipped catheter first is inserted into the fracture. The balloon is inflated to restore the height and shape of the vertebra before the cement is injected. Neva Nelson, 74, of Naperville, Ill., said a kyphoplasty that Malamis performed in October, 2009, has greatly reduced her pain in a vertebra in her lower back that she fractured after falling on ice. Before her kyphoplasty, Nelson had to sit on cushions. Walking, and especially standing, were painful. "I had to do something," she said. "I could not go on like that." Nelson said that since undergoing her kyphoplasty, "I don't have to worry about my back any more." In the controversial studies, patients were randomly assigned to receive a vertebroplasty or a placebo-like "sham" procedure. In the sham procedure, patients received an injection of anesthetic, but no cement. However, patients in severe pain are reluctant to enroll in a trial where there's a 50 percent chance of receiving a sham treatment. In one of the studies, researchers had to screen 1,813 patients to enroll just 131 subjects. In the other study, only 78 of 219 eligible patients were enrolled. This low enrollment rate raises the possibility that the patients who did enroll were not representative. Patients experience the greatest pain during the first three months after a compression fracture. Thereafter, pain gradually subsides. Thus, a vertebroplasty or kyphoplasty provides the greatest benefit when performed within a week or two of the fracture. But the studies enrolled patients up to 12 months after fractures. In addition to reducing pain and disability, a kyphoplasty can reduce the risk of subsequent fractures by improving the angle and height of the spine. The studies evaluated vertebroplasty alone, and did not include the more innovative and very different kyphoplasty procedure. Malamis suggests the medical community wait for the results of additional studies now underway before passing final judgment on vertebroplasty or kyphoplasty. In the mean time, he notes that Medicare still covers the procedures.
  •  
    Dr. Angelo Malamis says that 90 percent of his patients who have undergone a treatment called balloon kyphoplasty for vertebral fractures report significant reductions in pain and disability. But the number of kyphoplasty referrals Malamis has received from primary care doctors has dropped sharply since two controversial studies were published last year in the New England Journal of Medicine. In findings that have been disputed by two medical societies, researchers reported that a procedure related to kyphoplasty was not significantly better than a placebo-like procedure in reducing pain and disability.
Erich Feldmeier

@biogarage Ian Seppelt: #microbiome Human faeces pumped through a patient's nose used a... - 0 views

  •  
    "So far the treatment, known as faecal transplant, has been tested only on a drug resistant form of the bowel disease caused by the bacterium clostridium difficile. Antibiotics are unreliable against the superbug, but the transplant is 95% successful, saving patients from constant stomach cramps and chronic diarrhoea. "It sounds radical but it makes a lot of sense," said Seppelt on Thursday at a gathering of more than 4,000 Australasian anaesthetists and surgeons. "Usually patients are sufficiently miserable to go ahead, often using a donation from a relative." Healthy humans have about 100 times more bacteria cells in their gut than their own cells."
Erich Feldmeier

Cory Abate-Shen: A Molecular Signature Predictive of Indolent Prostate Cancer - 0 views

  •  
    Many newly diagnosed prostate cancers present as low Gleason score tumors that require no treatment intervention. Distinguishing the many indolent tumors from the minority of lethal ones remains a major clinical challenge. We now show that low Gleason score prostate tumors can be distinguished as indolent and aggressive subgroups on the basis of their expression of genes associated with aging and senescence. Using gene set enrichment analysis, we identified a 19-gene signature enriched in indolent prostate tumors. We then further classified this signature with a decision tree learning model to identify three genes-FGFR1, PMP22, and CDKN1A-that together accurately predicted outcome of low Gleason score tumors. Validation of this three-gene panel on independent cohorts confirmed its independent prognostic value as well as its ability to improve prognosis with currently used clinical nomograms. Furthermore, protein expression of this three-gene panel in biopsy samples distinguished Gleason 6 patients who failed surveillance over a 10-year period. We propose that this signature may be incorporated into prognostic assays for monitoring patients on active surveillance to facilitate appropriate courses of treatment.
veera90

Top 10 Data Integration and Management Challenges in the Pharma Value Chain | ACL Digital - 0 views

  •  
    Medicines and healthcare are synonymous globally. As treatments become more innovative, to address unmet clinical needs, it is important that there is innovation in the pharma value chain as well. In order that patients receive the right medicine, at the right time and the right place, there is a need for a complex value chain. The full set of activities that occur prior to a patient receiving a medicine, constitute the pharmaceutical value chain. This value would differ within markets and also between markets. https://www.acldigital.com/blogs/top-10-data-integration-and-management-challenges-pharma-value-chain
Walid Damouny

Vitamin D levels associated with survival in lymphoma patients - 0 views

  •  
    "A new study has found that the amount of vitamin D in patients being treated for diffuse large B-cell lymphoma was strongly associated with cancer progression and overall survival. The results will be presented at the annual meeting of the American Society of Hematology in New Orleans."
Skeptical Debunker

New study shows sepsis and pneumonia caused by hospital-acquired infections kill 48,000... - 1 views

  • This is the largest nationally representative study to date of the toll taken by sepsis and pneumonia, two conditions often caused by deadly microbes, including the antibiotic-resistant bacteria MRSA. Such infections can lead to longer hospital stays, serious complications and even death. "In many cases, these conditions could have been avoided with better infection control in hospitals," said Ramanan Laxminarayan, Ph.D., principal investigator for Extending the Cure, a project examining antibiotic resistance based at the Washington, D.C. think-tank Resources for the Future. "Infections that are acquired during the course of a hospital stay cost the United States a staggering amount in terms of lives lost and health care costs," he said. "Hospitals and other health care providers must act now to protect patients from this growing menace." Laxminarayan and his colleagues analyzed 69 million discharge records from hospitals in 40 states and identified two conditions caused by health care-associated infections: sepsis, a potentially lethal systemic response to infection and pneumonia, an infection of the lungs and respiratory tract. The researchers looked at infections that developed after hospitalization. They zeroed in on infections that are often preventable, like a serious bloodstream infection that occurs because of a lapse in sterile technique during surgery, and discovered that the cost of such infections can be quite high: For example, people who developed sepsis after surgery stayed in the hospital 11 days longer and the infections cost an extra $33,000 to treat per person. Even worse, the team found that nearly 20 percent of people who developed sepsis after surgery died as a result of the infection. "That's the tragedy of such cases," said Anup Malani, a study co-author, investigator at Extending the Cure, and professor at the University of Chicago. "In some cases, relatively healthy people check into the hospital for routine surgery. They develop sepsis because of a lapse in infection control—and they can die." The team also looked at pneumonia, an infection that can set in if a disease-causing microbe gets into the lungs—in some cases when a dirty ventilator tube is used. They found that people who developed pneumonia after surgery, which is also thought to be preventable, stayed in the hospital an extra 14 days. Such cases cost an extra $46,000 per person to treat. In 11 percent of the cases, the patient died as a result of the pneumonia infection.
  •  
    Two common conditions caused by hospital-acquired infections (HAIs) killed 48,000 people and ramped up health care costs by $8.1 billion in 2006 alone, according to a study released today in the Archives of Internal Medicine.
Tonny Johnson

How to Identify Clinically Successful Biomarkers? - 0 views

The decisive goal of clinical biomarker discovery should be intended for developing high quality and low-cost disease detection/monitoring assays with high diagnostic accuracy. Innovative approache...

personalized biomarker personal diagnostics imaging biomarkers diagnostic tools molecular next generation sequencing clinical cancer clinically useful discovery viable successful validation of

started by Tonny Johnson on 01 Oct 12 no follow-up yet
Erich Feldmeier

Peter Lockhart: No proof gum disease causes heart problems - Health - CBC News - 0 views

  •  
    "For 20 years, researchers have reported a potential link between gum disease and atherosclerotic heart disease from hardening of the arteries or stroke. "The message sent out by some in health-care professions, that heart attack and stroke are directly linked to gum disease, can distort the facts, alarm patients and perhaps shift the focus on prevention away from well-known risk factors for these diseases," said Dr. Peter Lockhart, a professor and chair of oral medicine at the Carolinas Medical Center in Charlotte, N.C. Lockhart wrote the heart group's new position statement in the journal Circulation. The statement was prepared after a three-year analysis of about 600 studies by an expert panel led by a dentist and a cardiologist."
Erich Feldmeier

Peter Rothwell, Daily aspirin at low doses reduces cancer deaths - University of Oxford - 0 views

  •  
    http://www.ox.ac.uk/media/news_stories/2010/101207.html Peter Rothwell: In this new work, scientists from Oxford, Edinburgh, London and Japan used data on over 670 deaths from cancer in a range of randomised trials involving over 25,000 people. These trials compared daily use of aspirin against no aspirin and were done originally to look for any preventative effect against heart disease. The results, published in the Lancet, showed that aspirin reduced death due to any cancer by around 20% during the trials. But the benefits of aspirin only became apparent after taking the drug for 5 years or more, suggesting aspirin works by slowing or preventing the early stages of the disease so that the effect is only seen much later. After 5 years of taking aspirin, the data from patients in the trials showed that death rates were 34% less for all cancers and as much as 54% less for gastrointestinal cancers, such as oesophagus, stomach, bowel, pancreas and liver cancers.
Janos Haits

Prevention of Organ Failure Centre of Excellence | Proof Centre - 0 views

  •  
    The PROOF (Prevention of Organ Failure) Centre is a not-for-profit organization that develops and implements blood-based biomarker tests to better manage patients with heart, lung and kidney failure and prevent disease progression. By embracing a cross-disciplinary team of people and uniting organizations including commercial partners, we can speed up the development of these tests, applying them sooner to improve and save lives.
thinkahol *

High-dose opiates could crack chronic pain : Nature News & Comment - 0 views

  •  
    Has a cheap and effective treatment for chronic pain been lying under clinicians' noses for decades? Researchers have found that a very high dose of an opiate drug that uses the same painkilling pathways as morphine can reset the nerve signals associated with continuous pain - at least in rats. If confirmed in humans, the procedure could reduce or eliminate the months or years that millions of patients spend on pain-managing prescription drugs. The results of the study are described today in Science1.
Erich Feldmeier

Daniel Mietchen Project: Communicating research as Beethoven suggested | RocketHub - 0 views

  •  
    "What are we aiming for? We want to change the way research is communicated, both amongst researchers, as well as with health practitioners, patients and the wider public. Inspired by Beethoven, we want to build a research version of his repository and try to tackle the question "What if the public scientific record would be updated directly as research proceeds?""
Erich Feldmeier

Biological Link between Cancer and Depression - The Naked Scientists May 2009 - 0 views

  •  
    "Leah Pyter: Well basically what we know is that patients with cancer have a higher likelihood of also developing depression at some point in their disease progression, so whether that occurred before and is predisposing them to cancer, or it's due to the tumours themselves, or other aspects of having the disease, we don't know. We were only studying right now whether the cancer itself can cause depression. Chris Smith: How could a tumour trigger depression, because a tumour can occur anywhere in the body, therefore at the remote sites in the brain, so how could it trigger changes in brain activity? Leah Pyter: Sure, well what we hypothesized was that the tumours themselves can produce cytokines which has been shown before. Chris Smith: These are inflammatory chemicals that drive the immune system? Leah Pyter: Right, exactly! And there is also a pile of research on how cytokines can access the brain specifically regions of the brain that are associated with depression and anxiety and emotional behaviours, and they can access the brain both tumourally through the blood, or neurally through the vegas nerves. "
Erich Feldmeier

Naturopathic Diaries - Confessions of a Naturopathic Doctor - 0 views

  •  
    "Britt Marie Hermes Former naturopathic doctor and "natural health expert." Current Master's of Science student in biomedicine. I share the hard truths about naturopathic education and practice to protect patients. Please don't be fooled by natural and alternative medicine. "
thinkahol *

Seeing the world with new eyes: Biosynthetic corneas restore vision in humans - 1 views

  •  
    "ScienceDaily (Aug. 25, 2010) - A new study from researchers in Canada and Sweden has shown that biosynthetic corneas can help regenerate and repair damaged eye tissue and improve vision in humans. The results, from an early phase clinical trial with 10 patients, are published in the August 25th, 2010 issue of Science Translational Medicine"
Walid Damouny

Grapefruit juice found to give cancer treatment a boost - 0 views

  •  
    Unlike most beverages, grapefruit juice contains a chemical that boosts the potency of many drugs in the body. To avoid a dangerously high dose of medication, patients are often advised to not wash down pills with grapefruit juice.
Charles Daney

The Niche: Stem cells, down to one factor - 0 views

  •  
    Differentiated human cells have been reprogrammed to an embryonic-like state with the addition of only one gene, rather than the standard four. This should advance techniques for the efficient production of high-quality patient-specific stem cells.
Charles Daney

Induced pluripotent stem cells, down to one factor : Nature Reports Stem Cells - 0 views

  •  
    Differentiated human cells have been reprogrammed to an embryonic-like state with the addition of only one gene rather than the standard four. This should advance techniques for the efficient production of high-quality patient-specific stem cells.
Walid Damouny

Less is more in cancer imaging - 0 views

  •  
    "When one diagnoses a cancer patient, it's important to gather as much information about that person as possible. But who would have thought an accurate diagnosis would depend on throwing some of that information away?"
1 - 20 of 34 Next ›
Showing 20 items per page